Blood endotypic signature in atopic dermatitis: The challenge in personalized medicine - 04/08/22
Doi : 10.1016/j.jaci.2022.06.005
Tom C. Chan, MD, PhD, Chia-Yu Chu, MD, PhD ⁎ 
Department of Dermatology, National Taiwan University Hospital, and the National Taiwan University College of Medicine, Taipei, Taiwan
∗Corresponding author: Chia-Yu Chu, MD, PhD, Department of Dermatology, National Taiwan University Hospital, 7 Chung-Shan South Rd, Taipei 10002, Taiwan.Department of DermatologyNational Taiwan University Hospital7 Chung-Shan South RdTaipei10002Taiwan
Key words : Atopic dermatitis, dupilumab, endotype, eosinophil, IL-5, phenotype, transcriptomics
Le texte complet de cet article est disponible en PDF.
| Supported by the Ministry of Science and Technology of Taiwan (grants 108-2314-B-002-177-MY3 and 109-2314-B-002-052-MY3) and the National Taiwan University (grant 111L7828). |
|
| Disclosure of potential conflict of interest: T. C. Chan is a speaker for Eli Lilly, AbbVie, and Sanofi. C.-Y. Chu is an investigator for AbbVie, Dermira, Eli Lilly, Novartis, Oneness Biotech, Pfizer, Regeneron, Roche, and Sanofi; a consultant for AbbVie, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, and Viatris; and a speaker for AbbVie, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, and Viatris. In addition, C.-Y. Chu is on advisory boards for AbbVie, Eli Lilly, Pfizer, Roche, Sanofi, and Viatris. |
© 2022
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 150 - N° 2
P. 294-296 - août 2022 Retour au numéro
Article précédent
- Eosinophilic gastrointestinal diseases make a name for themselves: A new consensus statement with updated nomenclature
- Benjamin L. Wright, Justin T. Schwartz, Melanie A. Ruffner, Glenn T. Furuta, Nirmala Gonsalves, Evan S. Dellon, Seema S. Aceves
- Does shining a spotlight on XIAP deficiency bring the role of allogeneic HCT into better focus?
- Rebecca A. Marsh
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?